US-based tissue regeneration specialist, Organogensis, has broken ground on the construction of the world’s largest automated living cell manufacturing plant in Canton, Massachusetts.
The company will use advanced robotic and modular manufacturing technologies at the new facility, which it claims will allow it to “leverage its leadership in the regenerative medicine field to attract substantial resources and jobs to Massachusetts over the next ten years.”
Organogenesis, which is in the midst of a major, multi-year expansion of its global headquarters, R&D and manufacturing facilities, attracted a host of local luminaries to the opening ceremony.
“Today we’re honoured to have so many state and local officials join us to commemorate the start of construction of this state-of-the-art facility,” said Organogenesis president and CEO, Geoff Mackay.
“This is a huge milestone for Organogenesis, as well as for the Commonwealth and for the regenerative medicine industry as a whole. We’re growing in Massachusetts in size, in revenue and capacity, and in order to keep pace with our rapid growth we’re hiring across all departments.”
Life science initiative
Organogensis is the latest company to benefit from the Massachusetts Life Sciences Initiative, which provides support for life sciences companies across the state through funding, planning advice and perhaps most importantly, sizeable tax breaks.
Susan Windham-Bannister, CEO of the Massachusetts Life Sciences Center, said: “This is a great example of the Life Sciences Initiative at work. The regenerative medicine industry was born here, in our state’s universities and labs, and we’re thrilled to watch this burgeoning industry thriving and creating jobs.”
State governor, Deval Patrick, said the new development was further proof that the Life Sciences Initiative was helping create jobs.
“This is an exciting day both for Organogenesis and the Commonwealth,” he said, “Massachusetts will soon be home to a landmark manufacturing facility that will produce living technology that advances healing around the world, while at the same time creating jobs and expansion here at home.
“This is just the sort of innovation and job creation that our Life Sciences Initiative was designed to encourage,” he added.